ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements with these filters
Star Health and Allied Insurance Company Ltd has scheduled a board meeting on October 27, 2026, to approve its quarterly and half-yearly financial results.
Star Health has withdrawn its application for reclassification of three promoter group entities. The Board of Directors approved this withdrawal via circular resolution.
Star Health has withdrawn its reclassification application for IDC Electronics Limited, a promoter group entity. Entities that have ceased to exist are also removed from promoter group.
Star Health delivered strong Q1 FY27 results with GWP growing 19% YoY to ₹4,287 Cr and PAT rising 25% to ₹550 Cr. Strategy focuses on proprietary distribution and underwriting profitability.
Star Health Q1 FY27 results show strong underwriting profitability and a 25% YoY PAT increase. Strategy focuses on proprietary distribution, retail health leadership, and digital/AI-driven claims precision.
Star Health marked its 20th anniversary with strong Q1 FY27 results, showing 19% GWP growth and consistent underwriting profitability despite a higher claims season.
Star Health delivered strong Q1 FY27 results with 19% GWP growth and significantly improved profitability, driven by its proprietary distribution channels and digital initiatives.
Star Health and Allied Insurance Company Ltd reported revenue from operations of ₹4,917 Cr (+13.4% YoY) and net profit of ₹549.7 Cr (+25.4% YoY) for Q1 FY27.
Star Health delivered strong FY26 performance with 13% Insurance Revenue growth and PAT of ₹911cr. Strategy focuses on retail indemnity expertise and digital-first operations.
Star Health Q4 & FY26 results show improved profitability with FY26 PAT at ₹911 Cr (up 16% YoY). Combined ratio improved to 98.8% from 101.1%.
Star Health delivered FY26 GWP of ₹20,369 Cr (16% YoY growth) with an improved Combined Ratio of 98.8%. Strategy focuses on retail indemnity expertise and digital-first operations.
Star Health reported FY26 GWP of ₹20,369 Cr (up 16% YoY) and PAT of ₹911 Cr. Strategy focuses on digital-first onboarding and proprietary agency network growth.
Star Health Q4 & FY26 presentation shows strong turnaround with FY26 PAT at ₹911 Cr (up 16% YoY) and Combined Ratio improving to 98.8%. Strategy focuses on digital onboarding and proprietary agency expansion.
Star Health delivered strong FY26 performance with GWP growing 16% YoY to ₹20,369 Cr and PAT increasing 16% to ₹911 Cr, supported by improved underwriting profitability and a combined ratio of 98.4%.
Star Health delivered FY26 Net Profit of ₹911 Cr (up 16% YoY) with Insurance Revenue growing 13% to ₹17,999 Cr. Focus remains on digital-first distribution and retail indemnity leadership.
Star Health Q4FY26/FY26 presentation shows a return to underwriting profitability and a 16% YoY increase in Net Profit (IND AS). Strategic focus remains on proprietary channels and digital onboarding.
Star Health delivered strong FY26 performance with PAT growth of 16% and a 45% jump in normalized PAT, driven by retail expansion and improved loss ratios.
Star Health FY26 results show strong profitable growth under IndAS with PAT at ₹911 Cr and Combined Ratio improved to 98.4%. Management maintains a focus on retail indemnity and digital-first strategies.
Star Health reported FY26 Net Profit of ₹911 Cr (up 16% YoY) with GWP reaching ₹20,369 Cr. Strategy focuses on retail indemnity expertise and digital-first customer engagement.
Star Health FY26 results show strong top-line growth and underwriting profitability. Management highlights digital transformation, agency network expansion, and improved claim efficiency as key drivers.
Star Health FY26 results show strong momentum with 13% Insurance Revenue growth and a significantly improved Combined Ratio of 98.4% (IndAS). Strategy focuses on proprietary agency channels and digital onboarding.
Star Health reported a turnaround in FY26 with underwriting profit of ₹206 Cr and GWP growth of 16% to ₹20,369 Cr. Management focused on profitable retail growth and loss ratio improvement.
Star Health FY26 Investor Presentation reports 13% Revenue growth to ₹17,999 Cr and 16% PAT growth to ₹911 Cr. Strategy focuses on retail indemnity, digital-first onboarding, and expanding the proprietary agency network.
Star Health FY26 results show strong profitable growth under IndAS, with Net Profit up 16% YoY and improved combined ratios across both IndAS and IGAAP frameworks.
Star Health FY26 Earnings Presentation shows a return to profitability with Net Profit (PAT) at ₹911 Cr and strong GWP growth of 16% YoY, driven by proprietary channels and digital onboarding.
Star Health delivered a turnaround in FY26, reporting an underwriting profit of ₹206 crores against a prior loss, despite a Q4 net loss due to mark-to-market equity volatility.
Star Health Q4FY26/FY26 presentation shows a shift to IndAS. FY26 PAT grew 16% YoY to ₹911 Cr with a Combined Ratio improvement to 98.8%. Strategy focuses on proprietary agency growth and digital onboarding.
Star Health FY26 Investor Presentation reports 13% Insurance Revenue growth and a shift to profitability with PAT of ₹911 Cr (up 16% YoY) and Combined Ratio improvement to 98.8%.
Star Health and Allied Insurance Company Ltd reported revenue from operations of ₹4,327 Cr (+13.9% YoY) and net profit of ₹111.3 Cr (+22160.0% YoY) for Q4 FY26.